NVT Logo (4).jpg
Novotech Identifies Decentralized Clinical Trials Potential and Challenges for Accelerating Global Biotech Clinical Trials in 2024
November 26, 2023 17:54 ET | Novotech
Novotech will be presenting at the Clinical Research Governance (CRGo) World Conference & International Clinical Trial Center Network (ICN) Symposium 2023
NVT Logo (4).jpg
Novotech Opens ChinaTrials 15 Conference with Workshop on how Biotechs can Accelerate Global Trials
November 07, 2023 02:24 ET | Novotech
Novotech CRO opens the ChinaTrials 15 conference in Shanghai, China on accelerating drug development.
NVT Logo (4).jpg
Novotech Publishes Whitepaper on Infectious Diseases Clinical Trials, Revealing Over 7,000 Trials Launched Worldwide
November 06, 2023 19:10 ET | Novotech
Novotech CRO today published the latest 2023 global clinical trial environment whitepaper focused on infectious diseases.
NVT Logo (4).jpg
Novotech Releases In-Depth 2023 Global Clinical Trial Landscape Reports on Hemophilia and Primary Biliary Cholangitis
November 02, 2023 03:48 ET | Novotech
Novotech today published the latest 2023 global clinical trial landscape reports on Primary Biliary Cholangitis (PBC) and Hemophilia.
NVT Logo (4).jpg
Novotech Announces Key Leadership Appointments: Rick Farris, North America Managing Director and Dr. David Ng, Global Vice President of Biometrics and Data
October 12, 2023 23:38 ET | Novotech
Novotech announces significant senior executive hires to further expand services for Novotech’s global biotech clients.
NVT Logo (4).jpg
Dr. Yooni Kim, Vice President of Clinical Services at Novotech, Delivers Keynote Address at Veeva Korea Summit
October 12, 2023 05:03 ET | Novotech
Dr. Yooni Kim, Vice President of Clinical Services at Novotech, served as a keynote speaker at the Veeva Korea Summit this week in Seoul, Korea
NVT Logo (4).jpg
Novotech Secures Consecutive Frost & Sullivan CRO Company of the Year Award
October 10, 2023 03:59 ET | Novotech
Novotech has been selected as the CRO Company of the Year 2023 by growth advisory and opportunity analytics firm Frost & Sullivan.
NVT Logo (4).jpg
Novotech Appoints Dr. Judith Ng-Cashin as Chief Medical Officer to Drive Global Medical Services
October 03, 2023 11:54 ET | Novotech
Novotech, the leading Asia Pacific-centred biotech CRO with global execution capabilities, announced today the appointment of Dr. Judith Ng-Cashin as CMO.
NVT Logo (4).jpg
Clinical Trials in China: Unlocking the Potential of Advanced Therapies Presented by Novotech and Endpoints News
September 11, 2023 16:32 ET | Novotech
BOSTON, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, announced today an expert panel webinar on Clinical Trials in...
NVT Logo (4).jpg
Novotech annoncée finaliste pour les Prix du leadership CRO en thérapie cellulaire et génique en Asie-Pacifique 2023
July 14, 2023 05:08 ET | Novotech
SINGAPOUR, 14 juill. 2023 (GLOBE NEWSWIRE) -- Novotech, la principale CRO en biotechnologie centrée sur l'Asie-Pacifique dont les capacités d'exécution sont mondiales, est finaliste pour les Prix de...